Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Leadership Change at Nestle Skin Health

By Drug Discovery Trends Editor | October 13, 2016

Humberto Antunes, Nestlé Skin Health CEO, has decided to give a new direction to his career and will leave Nestlé at the end of October 2016. Humberto Antunes joined Galderma in 1997, took over the leadership of Galderma’s worldwide operations in 2004 and finally became Nestlé Skin Health CEO in 2014. During this period the company became a global player in dermatology. Nestlé thanks Humberto Antunes for his contribution and wishes him every success in his new activities.

Paul Navarre is joining Nestlé and will take over from Humberto Antunes as Nestlé Skin HealthCEO on 1 November 2016. Paul Navarre is a French national with an MBA from the ISC Paris Business School who started his career with Procter & Gamble where he spent 15 years in different countries and positions involving both consumer goods and healthcare. He then joined Allergan, a global pharmaceutical company, in 2007 where, after various leadership roles over a period of 10 years, he most recently was President of Allergan International.

Paul Navarre’s consumer goods and healthcare background, his extensive international career and proven leadership skills make him ideally suited to take Nestlé Skin Health to the next level by further pursuing its strategy covering consumer solutions and self-medication, prescription as well as aesthetic and corrective products.


Filed Under: Drug Discovery

 

Related Articles Read More >

Bayer’s Lynkuet approved by FDA for menopausal hot flashes
How stereo-correct data can de-risk AI-driven drug discovery
eConsent as the digital foundation for modern clinical trials 
Female Patient Being Reassured By Doctor In Hospital Room
Q&A: Thermo Fisher’s Luke Wilson on hitting 100% dose delivery with patient-centric supply
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE